No Data
No Data
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Zai Lab Announces Director Resignation Amid Board Changes
Zai Lab Ltd Unveils Board of Directors and Leadership
ZAI LAB (09688): Chen Kaixian resigns as Independent Non-Executive Director.
ZAI LAB (09688) announced that Chen Kaixian wishes to resign from the Board of Directors to focus on Other professional and personal matters...
Zai Lab Limited (ZLAB) Upgraded to Buy: What Does It Mean for the Stock?
Highly resilient! Leading CRO companies have stabilized their fundamentals, but the shadow of the biosafety bill may still linger next year | Year-end review.
① In 2024, the USA Biodefense Act will disrupt CROs throughout the year and may continue next year; ② In the first three quarters of this year, over half of listed companies experienced revenue growth, and leading CROs demonstrated resilience; ③ Research on popular targets such as ADC, GLP-1, and bispecific antibodies will continue to be hot; ④ In 2025, the performance of leading CROs and small to medium enterprises may further diverge.
No Data